🇺🇸 DTacP-IPV combined vaccine (TETRAXIM™) in United States

DTacP-IPV combined vaccine (TETRAXIM™) (DTacP-IPV combined vaccine (TETRAXIM™)) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

DTacP-IPV combined vaccine (TETRAXIM™) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is DTacP-IPV combined vaccine (TETRAXIM™) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DTacP-IPV combined vaccine (TETRAXIM™) in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.